4.8 Article

A human tissue screen identifies a regulator of ER secretion as a brain-size determinant

Journal

SCIENCE
Volume 370, Issue 6519, Pages 935-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abb5390

Keywords

-

Funding

  1. EMBO postdoctoral fellowship [ALTF 966-2010]
  2. Austrian Science Fund [SFB-F78 P11, SFB-F78 P04, F 7803-B]
  3. Austrian Academy of Sciences
  4. Austrian Federal Ministry of Education, Science and Research
  5. city of Vienna
  6. European Research Council (ERC) under the European Union [695642]
  7. European Research Council (ERC) [695642] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Loss-of-function (LOF) screens provide a powerful approach to identify regulators in biological processes. Pioneered in laboratory animals, LOF screens of human genes are currently restricted to two-dimensional cell cultures, which hinders the testing of gene functions requiring tissue context. Here, we present CRISPR-lineage tracing at cellular resolution in heterogeneous tissue (CRISPR-LICHT), which enables parallel LOF studies in human cerebral organoid tissue. We used CRISPR-LICHT to test 173 microcephaly candidate genes, revealing 25 to be involved in known and uncharacterized microcephaly-associated pathways. We characterized IER3IP1, which regulates the endoplasmic reticulum (ER) function and extracellular matrix protein secretion crucial for tissue integrity, the dysregulation of which results in microcephaly. Our human tissue screening technology identifies microcephaly genes and mechanisms involved in brain-size control.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available